BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA FDA Compliance for Peptide Therapy and BPC 157 Holt Law A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences